Carrier Screening for Single-Gene Disorders – A Brief Review

1. Ferreira, CR. The burden of rare diseases. Am J Med Genet. 2019;179A:885-92.10.1002/ajmg.a.61124 Search in Google Scholar

2. Wakap SN, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165-73.10.1038/s41431-019-0508-0 Search in Google Scholar

3. Kumar P, Radhakrishnan J, Chowdhary MA, Giampietro PF. Prevalence and patterns of presentation of genetic disorders in a pediatric emergency department. Mayo Clin Proc. 2001;76(8):777-83.10.1016/S0025-6196(11)63220-5 Search in Google Scholar

4. Kirk EP, Barlow-Stewar K, Selvanathan A, Josephi-Taylor S, Worgan L, Rajagopalan S et al. Beyond the panel: preconception screening in consanguineous couples using the TruSight One “clinical exome”. Genet Med. 2019;21(3):608–12.10.1038/s41436-018-0082-929961766 Search in Google Scholar

5. Fareeda M, Afzala M. Genetics of consanguinity and inbreeding in health and disease. Ann Hum Biol. 2017;44(2):99-107.10.1080/03014460.2016.126514827892699 Search in Google Scholar

6. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med. 2011 Jan 12;3(65):65ra4.10.1126/scitranslmed.3001756374011621228398 Search in Google Scholar

7. Antonarakis, SE. Carrier screening for recessive disorders. Nat Rev Genet. 2019;20(9):549-61.10.1038/s41576-019-0134-231142809 Search in Google Scholar

8. Henneman L, Borry P, Chokoshvili D, Cornel CC, van El CG, Forzano F et al. Responsible implementation of expanded carrier screening. Eur J Hum Genet. 2016;24(6):e1 e12.10.1038/ejhg.2015.271486746426980105 Search in Google Scholar

9. Miller KE, Hoyt R, Rust S, Doerschuk R, Huang Y, Lin SM. The financial impact of genetic diseases in a pediatric accountable care organization. Public Health Front. 2020;8(58).10.3389/fpubh.2020.00058705930532181236 Search in Google Scholar

10. ACOG Committee opinion No. 691 Summary: Carrier Screening for Genetic Conditions. Obstetrics & Gynecology. 2017;129(3):597-9.10.1097/AOG.000000000000194828225421 Search in Google Scholar

11. van der Hout S, Dondorp W, de Wert G. The aims of expanded universal carrier screening: Autonomy, prevention, and responsible parenthood. Bioethics. 2019;33(5):568–76.10.1111/bioe.12555659408830734373 Search in Google Scholar

12. Mehta N, Lazarin GA, Spiegel E, Berentsen K, Brennan K, Giordano J et al. Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population. Genet Test Mol Biomark 2016;20(9):504-9.10.1089/gtmb.2015.0302531472327362553 Search in Google Scholar

13. van der Hout S, Holtkamp K, Henneman L, de Wert G, Dondorp W. Advantages of expanded universal carrier screening: what is at stake? Eur J Hum Genet. 2016;25(1):17-21.10.1038/ejhg.2016.125515976127677414 Search in Google Scholar

14. Muncie HL, Campbell JS. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4):339-44. Search in Google Scholar

15. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5(1):1-15.10.1186/1750-1172-5-11289311720492708 Search in Google Scholar

16. Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB. Carrier screening for Beta-thalassaemia: a review of international practice. Eur J Hum Genet. 2010;18(10):1077-83.10.1038/ejhg.2010.90298745220571509 Search in Google Scholar

17. Kalokairinou EM. The experience of ß-thalassemia and its prevention in Cyprus. Med Law. 2007;26:291-307. Search in Google Scholar

18. ACOG Committee. Practice bulletin No 78. Haemoglobinopathies in pregnancies. Obstet Gynecol. 2007;109(1):229-37.10.1097/00006250-200701000-00055 Search in Google Scholar

19. Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB. Carrier screening for Beta-thalassaemia: a review of international practice. Eur J Hum Genet. 2010;18(10):1077-83.10.1038/ejhg.2010.90 Search in Google Scholar

20. Cao A, Galanello FR, Melis MA, Angius A, Ximenes A, Rosatelli A et al. Prevention of Homozygous /8-Thalassemia by Carrier Screening and Prenatal Diagnosis in Sardinia. Am J Hum Genet. 1981;33(4):592. Search in Google Scholar

21. Cao A. Carrier screening and genetic counselling in β-thalassemia. Int J Hematol. 2002;76(2):105-13.10.1007/BF0316509812430909 Search in Google Scholar

22. Holtkamp KCA. Henneman L, Gillie JJP, Meijers-Heijboer H, Cornel MC, Lakeman P. Direct-to-consumer carrier screening for cystic fibrosis via a hospital website: a 6 year evaluation. J. Community Genet. 2018;10(2):249-57.10.1007/s12687-018-0388-y Search in Google Scholar

23. Castellani C, Macek Jr M, Cassiman JJ, Duff A, Massie J, ten KateLP et al. Benchmarks for Cystic Fibrosis carrier screening: A European consensus document. J Cyst Fibros. 2010;9(3):165-78.10.1016/j.jcf.2010.02.00520363197 Search in Google Scholar

24. Doksum T, Bernhardt BA, Holtzman NA. Carrier Screening for Cystic Fibrosis among Maryland Obstetricians before and after the 1997 NIH Consensus Conference. 5(2):111-6.10.1089/10906570175314556511551096 Search in Google Scholar

25. Ioannou L, McClaren BJ, Massie J, Lewis S, Metcalfe SA, Forrest L et al. Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research. Genet. Med. 2014;16(3):207-16.10.1038/gim.2013.125 Search in Google Scholar

26. Rowe CA, Wright CF. Expanded universal carrier screening and its implementation within a publicly funded healthcare service. J Community Genet. 2020;11(1):21-38.10.1007/s12687-019-00443-6696240531828606 Search in Google Scholar

27. Wapner RJ. A case for improved carrier screening. Contemporary ob/gyn. 2020;64(9):31-35. Search in Google Scholar

28. Cecchi AC, Vengoechea ES, Kaseniit KE, Hardy MW, Kiger LA, Mehta N et al. Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort. Mol Genet Genomic Med. 2019;7(8):e836.10.1002/mgg3.836668786031293106 Search in Google Scholar

29. Lazarin GA, Haque IS, Nazareth S, Iori K, Patterson AS, Jacobson AL et al. An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. Genet Med. 2013;15(3): 178-86.10.1038/gim.2012.114390855122975760 Search in Google Scholar

30. Evolving Science of Genetic Carrier Screening. AJMC Perspectives. 2018 Search in Google Scholar

31. Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Schneider A et al. ACMG position statementon prenatal/preconception expanded carrier screening. Genet Med. 2013;15(6):482-3.10.1038/gim.2013.4723619275 Search in Google Scholar

32. Srinivasan BS, Evans EA, Flannick J, Patterson AS, Chang CC, Pham T et al. Reproductive biomedicine online. 2010;21(4):537-51.10.1016/j.rbmo.2010.05.012 Search in Google Scholar

33. Azimi M, Schmaus K, Greger V, Neitzel D, Rochelle R, Dinh T. Carrier screening by next-generation sequencing: health benefits and cost effectiveness. Mol Genet Genomic Med. 2016;4(3):292-302.10.1002/mgg3.204486756327247957 Search in Google Scholar

34. Di Resta C, Galbiati S, Carrera P, Ferrari M. Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities. 2018;29(1): 4-14. Search in Google Scholar

35. Haque IS, Lazarin GA, Kang HP, Evans EA, Goldberg JD, Wapner JD. Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening. JAMA. 2016;316(7):734-42.10.1001/jama.2016.1113927533158 Search in Google Scholar

36. Holtkamp CA, Mathijssen IB, Lakeman P, van Maarle M, Dondorp WJ, Henneman L et al. Factors for successful implementation-based expanded carrier screening: learning from existing initiatives. Eur. J. Public Health. 2016;27(2):372-7.10.1093/eurpub/ckw110 Search in Google Scholar

37. Ben-Shachar R, Svenson A, Goldberg JD, Muzzey D. A data-driven evaluation of the size and content of expanded carrier screening panel. Genet Med. 2019;21(9):1931-9.10.1038/s41436-019-0466-5675231130816298 Search in Google Scholar

38. Lazarin GA, Hawthorne F, Collins NS, Platt EA, Evans EA, Haque IS. Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels. PLoS One, 2014;9(12):e114391.10.1371/journal.pone.0114391426239325494330 Search in Google Scholar

39. Platinga M, Birnie E, Abbott KM, Sinke RJ, Lucassen AM, Schuurmans M et al. Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases. Eur J Hum Genet. 2016;24(10):1417-23.10.1038/ejhg.2016.43502768827165008 Search in Google Scholar

40. Bell CJ, Dinwiddle DL, Miller NA, Hateley SL, Ganusova EE, Mudge J et al. Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing. Sci Transl Med. 2011;3(65):65ra4-65ra4.10.1126/scitranslmed.3001756374011621228398 Search in Google Scholar

41. Beachuamp KA, Muzzey D, Wong KK, Hogan GJ, Karimi K, Candille SI et al. Systematic design and comparison of expanded carrier screening. Genet Med. 2018;20(1):55-63.10.1038/gim.2017.69576315428640244 Search in Google Scholar

42. Wienke S, Brown K, Farmer M, Strange C. Expanded carrier screening panels-does bigger mean better? J Community Genet. 2014;5(2):191-8.10.1007/s12687-013-0169-6395546024062228 Search in Google Scholar

43. Dungan J. Expanded carrier screening: what the reproductive endocrinologist needs to know. Fertil Steril. 2019;109(2):183-9.10.1016/j.fertnstert.2017.11.03029447660 Search in Google Scholar

44. Prior TW. Next-generation carrier screening: are we ready? Genome Med. 2014;6(8):1-3.10.1186/s13073-014-0062-x425443625473430 Search in Google Scholar

45. Platinga M, Birnie E, Schuurmans J, Buitenhuis AH, Boersma E, Lucassen AM et al. Expanded carrier screening for autosomal recessive conditions in health care: Arguments for a couple-based approach and examination of couples’ views. Prenat Diagn. 2018;39(5):369-78.10.1002/pd.5437659398630756401 Search in Google Scholar

46. Capalbo A, Valero RA, Jimenez-Almanaz J, Pardo PM, Fabiani M, Jimenez D et al. Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes. PLoS Genet. 2019;15(10):e1008409.10.1371/journal.pgen.1008409679723531589614 Search in Google Scholar

47. Rose NC, Wick M. Current recommendations: Screening for Mendelian disorders. Semin Perinatol. 2016;40(1):23-8.10.1053/j.semperi.2015.11.00426706396 Search in Google Scholar

48. Schuurmans J, Birnie E, van den Heuvel LM, Platinga M, Lucassen A, van der Kolk DM et al. Feasibility of couple-based carrier screening offered by general practitioners. Eur J Hum Genet. 2019;27(5):691-700.10.1038/s41431-019-0351-3646200830742054 Search in Google Scholar

49. Leung ML, McAdoo S, Watson D, Stumm K, Harr M, Wang Xiang et al. A transparent approach to calculate detection rate and residual risk for carrier screening. J Mol Diagn. 2021;23(1):91-102.10.1016/j.jmoldx.2020.10.00933349347 Search in Google Scholar

50. Lazarin GA, Haque IS. Expanded carrier screening: A review of early implementation and literature. Semin Perinatol 2016;40(1):29-34.10.1053/j.semperi.2015.11.00526718446 Search in Google Scholar

51. Fridman H, Behar DM, Carmi S, Levy-Lahad E. Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants. Genet Med. 2020;22(3): 646-53.10.1038/s41436-019-0676-x31624327 Search in Google Scholar

52. Xi Y, Chen G, Lei C, Wu J, Zhang S, Xiao M et al. Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology. Mol Genet Genomic Med. 2020;8:e1340.10.1002/mgg3.1340750741132573981 Search in Google Scholar

53. Edwards JG, Feldman G, Goldberg J, Gregg AR, Norton ME, Rose NC et al. Expanded carrier screening in reproductive medicine—points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstet Gynecol. 2015;125(3):653-62.10.1097/AOG.000000000000066625730230 Search in Google Scholar

54. Abacan M, Alsubaie L, Borlow-Stewart K, Caanen B, Cordier C, Courtney E et al. The Global State of the Genetic Counseling Profession. Eur J Hum Genet. 2019;27(2):183-97.10.1038/s41431-018-0252-x633687130291341 Search in Google Scholar

55. Fakih A, Spector-Bagdady K. Should clinicians leave “expanded” carrier screening decisions to patients? AMA J Ethics. 2019;21(10):E858.10.1001/amajethics.2019.858698838631651385 Search in Google Scholar

56. Cho D, McGowan ML, Metcalfe J, Sharp RR. Expanded carrier screening in reproductive healthcare: perspectives from genetics professionals. Hum. Reprod. 2013;28(6):1725-30.10.1093/humrep/det091 Search in Google Scholar

57. Kraft SA, Duenas D, Wilfond BS, Goddard KAB. The evolving landscape of expanded carrier screening: challenges and opportunities. Genet. Med. 2019;21(4):790-7.10.1038/s41436-018-0273-4 Search in Google Scholar